|
ZNF639 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.380500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.838810E-01 |
| Normal-vs-Stage2 |
9.531800E-02 |
| Normal-vs-Stage3 |
3.491500E-02 |
| Normal-vs-Stage4 |
3.878300E-02 |
| Stage1-vs-Stage2 |
3.111200E-01 |
| Stage1-vs-Stage3 |
2.034600E-01 |
| Stage1-vs-Stage4 |
2.860000E-01 |
| Stage2-vs-Stage3 |
9.364600E-01 |
| Stage2-vs-Stage4 |
7.743400E-01 |
| Stage3-vs-Stage4 |
7.934400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.621800E-02 |
| Normal-vs-AfricanAmerican |
4.227500E-02 |
| Normal-vs-Asian |
3.065000E-01 |
| Caucasian-vs-AfricanAmerican |
5.211400E-01 |
| Caucasian-vs-Asian |
8.771200E-01 |
| AfricanAmerican-vs-Asian |
9.111000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.942600E-03 |
| Normal-vs-Female |
3.792800E-01 |
| Male-vs-Female |
8.348500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.828600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.845380E-01 |
| Normal-vs-Age(61-80Yrs) |
1.068200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.547650E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.964200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.968600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.980440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.924380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.415400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.261200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.804600E-01 |
| Normal-vs-Grade 2 |
7.013200E-01 |
| Normal-vs-Grade 3 |
2.355900E-03 |
| Normal-vs-Grade 4 |
2.543100E-03 |
| Grade 1-vs-Grade 2 |
5.446000E-01 |
| Grade 1-vs-Grade 3 |
9.849900E-02 |
| Grade 1-vs-Grade 4 |
4.480500E-02 |
| Grade 2-vs-Grade 3 |
5.284900E-03 |
| Grade 2-vs-Grade 4 |
7.537400E-03 |
| Grade 3-vs-Grade 4 |
4.982600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.731000E-01 |
| Normal-vs-ccB subtype |
1.010830E-01 |
| ccA subtype-vs-ccB subtype |
1.839610E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.197400E-01 |
| Normal-vs-N1 |
3.275900E-02 |
| N0-vs-N1 |
4.031200E-01 |
|
|
